Q4 results May 12, 2026: Tata Power, Dr Reddy

A heavy earnings day for Indian markets

Over 100 companies are scheduled to announce January to March quarter (Q4FY26) results on Tuesday, May 12, 2026. The list features large, widely tracked names across power, pharmaceuticals, electronics manufacturing services, paints, textiles, and financial services. With results season in full swing, investors typically watch such high-density days for sector cues, management commentary, and guidance that can shape near-term trading.

This May 12 batch includes Tata Power, Dr Reddy’s Laboratories, Dixon Technologies, Torrent Power, Berger Paints India, and Max Financial Services. It also includes mid and small-cap companies spanning chemicals, consumer, real estate, travel, and industrials, widening the set of potential stock-specific reactions.

Key companies announcing Q4FY26 results on May 12

The scheduled reporters include integrated power utilities, pharma majors, and consumer-facing brands. Alongside the headline names, the list also includes KPR Mill and Neuland Laboratories. In pharma and healthcare, Pfizer and hospital chain Park Medi World are among those expected to report.

In industrials and manufacturing, MTAR Technologies and Inox India are part of the May 12 line-up. Consumer and retail-linked names include Ethos and Thomas Cook (India). Technology and new-age segments also appear in the form of Nazara Technologies and One Mobikwik Systems.

A broader list spans several sectors

The May 12 earnings calendar extends to companies such as V-Guard Industries, Clean Max Enviro Energy Solutions, Vinati Organics, Borosil Renewables, Kalpataru, Keystone Realtors, Texmaco Rail and Engineering, NIIT Learning Systems, Gopal Snacks, Indraprastha Medical Corporation, Novartis India, Bliss GVS Pharma, Stove Kraft, GTL Infrastructure, Sai Silks Kalamandir, Seshasayee Paper and Boards, Huhtamaki India, and Subex.

The long tail of scheduled results also includes a range of smaller companies, reflecting how concentrated the mid-May reporting window is this quarter.

Where the May 12 results sit in the wider Q4FY26 cycle

The reporting rush is not limited to a single day. Close to 500 companies are scheduled to announce Q4FY26 financial results between May 11 and 16. Investors and analysts have been tracking corporate performance across sectors including manufacturing, information technology, auto, pharma, consumer goods, and logistics.

The broader schedule mentioned for the week includes companies such as JSW Energy, Bharti Airtel, Tata Steel, Philips India, and Bajaj Electricals. For May 11, the list of major results includes Canara Bank, JSW Energy, Indian Hotels Company, Nuvama Wealth Management, and PVR Inox.

Dr Reddy’s: filing, board meeting, and earnings call schedule

Dr Reddy’s Laboratories has submitted a regulatory filing under Regulation 30 to notify investors about the timing of its Q4 and full-year FY26 results. The company is set to release its financial performance for the quarter and year ended March 31, 2026, on Tuesday, May 12, 2026, following a Board Meeting.

The company has also planned an earnings call at 19:30 PM IST (10:00 AM ET). It said results will be distributed through stock exchanges, media, its website, and email. A press meet presentation is expected to be available on the company website (www.drreddys.com), and the audio recording and transcript of the call are also expected to be posted online.

Dr Reddy’s Q4 preview: what brokerages are tracking

Brokerage expectations tracked by Business Standard point to a year-on-year decline in key profitability metrics for Dr Reddy’s in Q4FY26. Net profit is expected at ₹1,035 crore, compared with ₹1,587 crore in Q4FY25, implying a year-on-year decline of 34% on average. On a quarter-on-quarter basis, the bottom line is projected to decrease by 13%.

Revenue for the quarter under review is expected to decline 3.35% year-on-year to ₹8,220 crore, versus ₹8,506 crore in the corresponding quarter of the previous fiscal. Sequentially, revenue is expected to fall 5.8% from ₹8,726.8 crore in the December 2025 quarter.

Ebitda is expected to decline over 20% to ₹1,629 crore in Q4FY26, compared to ₹2,051 crore in the year-ago period. It is also expected to fall around 14% quarter-on-quarter from ₹1,895 crore in the previous quarter.

What is behind the key drivers mentioned in previews

Kotak Institutional Equities expects Dr Reddy’s to see a 10% year-on-year decline in overall sales, linking the drag to North America and the tapering off of generic Revlimid, alongside shelf stock adjustments. The same preview noted that the domestic market remains a significant growth driver, with projections of double-digit expansion for the India business between 15% and 18% year-on-year.

A separate preview also flagged the launch of generic semaglutide as a key highlight, describing it as a tailwind seen in March with expectations of faster growth heading into FY2027.

Centrum Broking expects a 15% year-on-year jump in domestic formulations to ₹1,400 crore, driven by growth in key therapies and integration of the Nestle and Sanofi portfolios.

Market impact: why May 12 can move multiple pockets

A large earnings day can increase stock-specific volatility, particularly when management commentary changes market assumptions on demand, pricing, margins, capex, or regulatory developments. With power utilities (Tata Power, Torrent Power), EMS (Dixon Technologies), and FMCG-like consumption exposure (Berger Paints) reporting on the same day, investors often compare signals across sectors rather than viewing each result in isolation.

For Dr Reddy’s specifically, the combination of revenue expectations, Ebitda trajectory, and segment commentary is likely to be closely watched, given that previews point to muted Ebitda growth across the broader pharma set in the March 2026 quarter.

Summary table: notable May 12 reporters

Key numbers table: Dr Reddy’s expectations cited in previews

Conclusion

May 12 is set to be one of the busiest days of the Q4FY26 reporting season, with over 100 companies scheduled to post results, led by Tata Power, Dr Reddy’s Laboratories, Dixon Technologies, Torrent Power, and Berger Paints India. For Dr Reddy’s, the company has also outlined a formal results and communication schedule, including a Board Meeting, results dissemination channels, and an earnings call at 19:30 PM IST. Investors will be tracking the reported numbers against the expectations cited in previews, along with management commentary once the results are out.